Clinical Outcome of Long-Term Renal Transplant Survivors: A Nephrourologic Approach von Awad, M.C, da Silva, E.A, Souza, E, Damião, R

Volltext

Modeling of the Transmission of Coronaviruses, Measles Virus, Influenza Virus, Mycobacterium tuberculosis, and Legionella pneumophila in Dental Clinics von Zemouri, C., Awad, S.F., Volgenant, C.M.C., Crielaard, W., Laheij, A.M.G.A., de Soet, J.J.

Volltext

Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) in NSCLC with brain metastases: Pooled analysis of KEYNOTE-021, 189, and 407 von Powell, S.F., Abreu, D Rodriguez, Langer, C.J., Tafreshi, A., Paz-Ares, L., Kopp, H.-G., Rodríguez-Cid, J., Kowalski, D., Cheng, Y., Kurata, T., Awad, M.M., Lin, J., Zhao, B., Pietanza, M.C., Piperdi, B., Garassino, M.C.

Volltext

1483PD - Pembrolizumab (pembro) plus platinum-based chemotherapy (chemo) in NSCLC with brain metastases: Pooled analysis of KEYNOTE-021, 189, and 407 von Powell, S.F., Abreu, D Rodriguez, Langer, C.J., Tafreshi, A., Paz-Ares, L., Kopp, H.-G., Rodríguez-Cid, J., Kowalski, D., Cheng, Y., Kurata, T., Awad, M.M., Lin, J., Zhao, B., Pietanza, M.C., Piperdi, B., Garassino, M.C.

Volltext

Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes von Eduful, Benjamin J, O’Byrne, Sean N, Temme, Louisa, Asquith, Christopher R. M, Liang, Yi, Picado, Alfredo, Pilotte, Joseph R, Hossain, Mohammad Anwar, Wells, Carrow I, Zuercher, William J, Catta-Preta, Carolina M. C, Zonzini Ramos, Priscila, Santiago, André de S, Couñago, Rafael M, Langendorf, Christopher G, Nay, Kévin, Oakhill, Jonathan S, Pulliam, Thomas L, Lin, Chenchu, Awad, Dominik, Willson, Timothy M, Frigo, Daniel E, Scott, John W, Drewry, David H

Volltext

MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates von Greene, J M, Dash, P, Roy, S, McMurtrey, C, Awad, W, Reed, J S, Hammond, K B, Abdulhaqq, S, Wu, H L, Burwitz, B J, Roth, B F, Morrow, D W, Ford, J C, Xu, G, Bae, J Y, Crank, H, Legasse, A W, Dang, T H, Greenaway, H Y, Kurniawan, M, Gold, M C, Harriff, M J, Lewinsohn, D A, Park, B S, Axthelm, M K, Stanton, J J, Hansen, S G, Picker, L J, Venturi, V, Hildebrand, W, Thomas, P G, Lewinsohn, D M, Adams, E J, Sacha, J B

Volltext

1782MO Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC von Kim, H.R., Awad, M.M., Navarro, A., Gottfried, M., Peters, S., Csőszi, T., Cheema, P.K., Rodriguez-Abreu, D., Wollner, M., Yang, J.C-H., Mazieres, J., Orlandi, F.J., Luft, A., Gümüş, M., Kato, T., Kalemkerian, G.P., Luo, Y., Santorelli, M.L., Pietanza, M.C., Rudin, C.M.

Volltext

3100Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis von Awad, K., Serban, M.C., Penson, P., Mikhailidis, D.P., Toth, P.P., Jones, S.R., Rysz, J., Rizzo, M., Howard, G., Lip, G.Y.H., Banach, M.

Volltext

OA04.05 KEYNOTE-021: TMB and Outcomes for Carboplatin and Pemetrexed With or Without Pembrolizumab for Nonsquamous NSCLC von Langer, C., Gadgeel, S., Borghaei, H., Patnaik, A., Powell, S., Gentzler, R., Yang, J.C., Gubens, M., Sequist, L., Awad, M., Cristescu, R., Aurora-Garg, D., Albright, A., Loboda, A., Kobie, J., Lunceford, J., Ayers, M., Lubiniecki, G., Piperdi, B., Pietanza, M.C., Papadimitrakopoulou, V.

Volltext

P103 THE EFFECTS OF FASTING AND REFEEDING WITH A ‘METABOLIC PRECONDITIONING’ DRINK ON SUBSTRATE RESERVES AND MITOCHONDRIAL FUNCTION: POTENTIAL MECHANISMS BY WHICH PREOPERATIVE FEED... von Awad, S, Stephenson, M.C, Placidi, E, Marciani, L, Constantin-Teodosiu, D, Gowland, P.A, Spiller, R.C, Fearon, K.C.H, Morris, P.G, Macdonald, I.A, Lobo, D.N

Volltext